133 related articles for article (PubMed ID: 37804962)
1. Weighted hypergraph learning and adaptive inductive matrix completion for SARS-CoV-2 drug repositioning.
Ma Y; Zhong J; Zhu N
Methods; 2023 Nov; 219():102-110. PubMed ID: 37804962
[TBL] [Abstract][Full Text] [Related]
2. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
3. Generalized matrix factorization based on weighted hypergraph learning for microbe-drug association prediction.
Ma Y; Liu Q
Comput Biol Med; 2022 Jun; 145():105503. PubMed ID: 35427986
[TBL] [Abstract][Full Text] [Related]
4. SAveRUNNER: an R-based tool for drug repurposing.
Fiscon G; Paci P
BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
[TBL] [Abstract][Full Text] [Related]
5. An Ensemble Matrix Completion Model for Predicting Potential Drugs Against SARS-CoV-2.
Li W; Wang S; Xu J
Front Microbiol; 2021; 12():694534. PubMed ID: 34367094
[TBL] [Abstract][Full Text] [Related]
6. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
7. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
Goel B; Bhardwaj N; Tripathi N; Jain SK
Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
[TBL] [Abstract][Full Text] [Related]
8. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
Akilesh SM; J R; Palanisamy D; Wadhwani A
Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
[TBL] [Abstract][Full Text] [Related]
9. A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
Yao Y; Zhang Y; Li Z; Chen Z; Wang X; Li Z; Yu L; Cheng X; Li W; Jiang WJ; Wu HJ; Feng Z; Sun J; Fei T
Biochem Biophys Res Commun; 2023 Oct; 675():113-121. PubMed ID: 37467664
[TBL] [Abstract][Full Text] [Related]
10. Perspectives for repurposing drugs for the coronavirus disease 2019.
Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
[TBL] [Abstract][Full Text] [Related]
11. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
[TBL] [Abstract][Full Text] [Related]
12. Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19.
Tang X; Cai L; Meng Y; Xu J; Lu C; Yang J
Front Immunol; 2020; 11():603615. PubMed ID: 33584672
[TBL] [Abstract][Full Text] [Related]
13. Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.
Barsi S; Papp H; Valdeolivas A; Tóth DJ; Kuczmog A; Madai M; Hunyady L; Várnai P; Saez-Rodriguez J; Jakab F; Szalai B
PLoS Comput Biol; 2022 Apr; 18(4):e1010021. PubMed ID: 35404937
[TBL] [Abstract][Full Text] [Related]
14. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
Yadav M; Dhagat S; Eswari JS
Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
[TBL] [Abstract][Full Text] [Related]
15. Drug repositioning based on multi-view learning with matrix completion.
Yan Y; Yang M; Zhao H; Duan G; Peng X; Wang J
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35289352
[TBL] [Abstract][Full Text] [Related]
16. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
Mishra J; Prasun C; Sahoo PK; Nair MS
Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new drug indications for COVID-19: A drug repurposing approach.
Kumari P; Pradhan B; Koromina M; Patrinos GP; Steen KV
PLoS One; 2022; 17(5):e0267095. PubMed ID: 35609015
[TBL] [Abstract][Full Text] [Related]
19. Drug repurposing approach to fight COVID-19.
Singh TU; Parida S; Lingaraju MC; Kesavan M; Kumar D; Singh RK
Pharmacol Rep; 2020 Dec; 72(6):1479-1508. PubMed ID: 32889701
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: Discovery, diagnostics and drug development.
Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
